TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment of Newly Diagnosed Childhood CNS Teratomas
Source: Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: October 8, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Teratomas are designated as mature or immature on the basis of the absence or presence of differentiated tissues. The Japanese Pediatric Brain Tumor Study Group stratifies teratomas for classification and intensity of treatment (chemotherapy and radiation) into a good-prognosis group (mature teratomas) and an intermediate-prognosis group (immature teratomas) (see Table 2), while the Children’s Oncology Group includes immature teratomas with other nongerminomatous germ cell tumors.
Source links and citations
Treatment options for newly diagnosed childhood central nervous system (CNS) teratomas include the following:
Gross-total resection.
Source links and citations
Continue within this section
Preserved source evidence · Not medical advice